Evidence map›Paper›PMID 35467977›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

FAF1 blocks ferroptosis by inhibiting peroxidation of polyunsaturated fatty acids.

Shaojie Cui, Glenn Simmons, Goncalo Vale, Yaqin Deng, Jungyeon Kim, Hyeonwoo Kim, Ruihui Zhang, Jeffrey G McDonald, Jin Ye

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Ferroptosis: The Demise of Cells Through Phospholipid Peroxidation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. MAFLD: a ferroptotic disease.Trends in molecular medicine · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Iron Dysregulation in Cardiovascular Diseases.Reviews in cardiovascular medicine · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shaojie CuiDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-6034-7351
Glenn SimmonsDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0003-2081-5672
Goncalo ValeDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0003-1104-0289
Yaqin DengDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Jungyeon KimDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Hyeonwoo KimDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Ruihui ZhangMolecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0003-1010-7242
Jeffrey G McDonaldDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Jin YeDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-3179-4777
The University of Texas Southwestern Medical Center · US

Funding

TRANSCRIPTIONAL REGULATION OF LDL RECEPTOR PROMOTERP01HL020948 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GOLDSTEIN, JOSEPH L · 1985 to 2021
$103.1M
Topological regulation of transmembrane proteins through Regulated Alternative TranslocationR35GM140851 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI YE, JIN · 2021 to 2025
$2.2M
Proteolytic activation of CREB3L1 in treating cancers and tissue fibrosisR01GM116106 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI YE, JIN · 2015 to 2018
$1.6M
NHLBI NIH HHS P01 HL020948NIGMS NIH HHS R01 GM116106NIGMS NIH HHS R35 GM140851
6 · The paper itself

Abstract

Iron-dependent peroxidation of polyunsaturated fatty acids (PUFAs) leads to ferroptosis. While detoxification reactions removing lipid peroxides in phospholipids such as that catalyzed by glutathione peroxidase 4 (GPX4) protect cells from ferroptosis, the mechanism through which cells prevent PUFA peroxidation was not completely understood. We previously identified Fas-associated factor 1 (FAF1) as a protein directly interacting with free PUFAs through its UAS domain. Here we report that this interaction is crucial to protect cells from ferroptosis. In the absence of FAF1, cultured cells became sensitive to ferroptosis upon exposure to physiological levels of PUFAs, and mice developed hepatic injury upon consuming a diet enriched in PUFA. Mechanistically, we demonstrate that FAF1 assembles a globular structure that sequesters free PUFAs into a hydrophobic core, a reaction that prevents PUFA peroxidation by limiting its access to iron. Our study suggests that peroxidation of free PUFAs contributes to ferroptosis, and FAF1 acts upstream of GPX4 to prevents initiation of ferroptosis by limiting peroxidation of free PUFAs.

Indexed as

FerroptosisAnimalsCell DeathCell LineCells, CulturedFatty Acids, UnsaturatedMiceFatty Acids, UnsaturatedFAF1ferroptosispolyunsaturated fatty acids

Identifiers

PMID35467977
PMCPMC9169925
OpenAlexW4225746642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.